NIH Roadmap Epigenomics Program NIH Roadmap Epigenome Mapping Center

By Jeffrey Norris on October 2, 2008

Center director and principal investigator: Joe Costello, PhD, UCSF. Associate professor of neurological surgery, Karen Osney Brownstein Endowed Chair in Molecular Neuro-Oncology and director of the epigenetics division of the UCSF Cell Cycling and Signaling Program.

Co-director: Marco Marra, PhD, British Columbia Cancer Agency Genome Sciences Centre. Professor of medical genetics, University of British Columbia; director of the British Columbia Cancer Agency Genome Sciences Centre in Vancouver.

Co-investigator: Steven Jones, PhD, British Columbia Cancer Agency Genome Sciences Centre. Associate director/Head Bioinformatics, British Columbia Cancer Agency Genome Sciences Centre; assistant professor at Simon Fraser University.

Co-investigator: Martin Hirst, PhD, British Columbia Cancer Agency Genome Sciences Centre. Functional Genomics platform leader, adjunct professor of molecular biology and biochemistry at Simon Fraser University.

Co-investigator: Peggy Farnham, PhD, UC Davis. Professor of pharmacology, associate director of genomics at UC Davis Genome Center and faculty director of Expression Analysis Core.

Co-investigator: David Haussler, PhD, UC Santa Cruz. Howard Hughes Medical Institute investigator, director of the Center for Biomolecular Science and Engineering, and professor of biomolecular engineering; scientific co-director, California Institute for Quantitative Biosciences (QB3).

Co-investigator: James Kent, PhD, UC Santa Cruz. Research scientist.

Co-investigator: Ting Wang, PhD, UC Santa Cruz. Postdoctoral scholar.

Co-investigator: Arturo Alvarez-Buylla, PhD, UCSF. Heather and Melanie Muss Endowed Chair, professor of neurological surgery.

Co-investigator: Susan Fisher, PhD, UCSF. professor and head, Human Embryonic Stem Cell Research Center.

Co-investigator: Michael McManus, PhD, UCSF. Assistant professor, Diabetes Center, and director of W.M. Keck Center for Noncoding RNAs.

Co-investigator: Thea Tlsty, PhD, UCSF. Professor of pathology and director of Cell Cycling and Signaling Program.

Co-investigator: Arthur Weiss, MD, PhD, UCSF. Howard Hughes Medical Institute investigator, Ephraim P. Engleman Distinguished Professor and chief of Division of Rheumatology.

Explore UCSF News

IN MEMORIAM

UCSF ALS Center's Founding Director Dies of the Disease He Studied

CLINICAL RESEARCH

New Lung Cancer Test Predicts Survival

In the two largest clinical studies ever conducted on the molecular genetics of lung cancer, an international team led by scientists at the University of California, San Francisco (UCSF) has demonstrated that an available molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.

EDUCATION

UCSF's New Dean Wants to Raise Profile of Graduate Education

BIOINFORMATICS

UCSF School of Medicine Leaders Explore Bioinformatics

Bioinformatics was the focus of this year’s daylong UCSF School of Medicine leadership retreat on January 20. Campus leaders examined the question of how to optimally develop, organize and integrate clinical-outcome data, research data, business intelligence, and population data.